Halozyme Therapeutics
HALO
#2269
Rank
โ‚ฌ7.19 B
Marketcap
61,16ย โ‚ฌ
Share price
-2.62%
Change (1 day)
17.10%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: โ‚ฌ7.19 Billion

As of January 2026 Halozyme Therapeutics has a market cap of โ‚ฌ7.19 Billion. This makes Halozyme Therapeutics the world's 2269th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ7.19 B4.32%
2025โ‚ฌ6.89 B17.16%
2024โ‚ฌ5.88 B33.24%
2023โ‚ฌ4.41 B-38.42%
2022โ‚ฌ7.17 B43.48%
2021โ‚ฌ4.99 B6.49%
2020โ‚ฌ4.69 B116.94%
2019โ‚ฌ2.16 B16.91%
2018โ‚ฌ1.85 B-23%
2017โ‚ฌ2.40 B97.63%
2016โ‚ฌ1.21 B-40.12%
2015โ‚ฌ2.03 B103.62%
2014โ‚ฌ0.99 B-19.76%
2013โ‚ฌ1.24 B117.44%
2012โ‚ฌ0.57 B-24.71%
2011โ‚ฌ0.75 B26.79%
2010โ‚ฌ0.59 B59.44%
2009โ‚ฌ0.37 B15.14%
2008โ‚ฌ0.32 B-14%
2007โ‚ฌ0.37 B-9.54%
2006โ‚ฌ0.41 B353.05%
2005โ‚ฌ92.56 M16%
2004โ‚ฌ79.79 M

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Halozyme Therapeutics was reported to be:

โ‚ฌ7.38 Billion
by Nasdaq info icon info icon
โ‚ฌ7.38 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
MannKind Corp
MNKD
โ‚ฌ1.48 B-79.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ796.42 B 10,973.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ8.98 B 24.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ126.39 B 1,657.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ99.04 B 1,277.07%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
โ‚ฌ454.52 B 6,219.62%๐Ÿ‡บ๐Ÿ‡ธ USA